MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...

Two new studies, one based on households in southeast Michigan and one involving hospitalized Japanese adults, compare ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

It appears RSV and COVID have peaked, but the flu is still rising. The number and rate of positive cases of COVID is notably ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

“Areas with lower vaccination rates, colder weather and higher population density are seeing higher infection rates,” said Dr ...